Stacey Ma, incoming Gilead head of pharma development and manufacturing

Gilead poach­es new phar­ma de­vel­op­ment and man­u­fac­tur­ing chief from cell ther­a­py 2.0 play­er

Gilead has raid­ed one of the up-and-com­ing cell ther­a­py 2.0 biotechs to find its new head of phar­ma de­vel­op­ment and man­u­fac­tur­ing.

Dan O’Day’s phar­ma play­er has re­cruit­ed Stacey Ma from Sana Biotech­nol­o­gy for the se­nior ex­ec­u­tive team. A Genen­tech vet, Ma has been head of tech­ni­cal op­er­a­tions at Sana, which has just opt­ed to change up its man­u­fac­tur­ing build­ing plans in fa­vor of Seat­tle over their orig­i­nal site in Cal­i­for­nia. Sana CEO Steve Harr had proud­ly held Ma up as one of the top R&D ex­ecs at the com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.